79280356 - MIDATECH PHARMA

Information

  • Trademark
  • 79280356
  • Serial Number
    79280356
  • Registration Number
    6263411
  • Filing Date
    November 14, 2019
    5 years ago
  • Registration Date
    February 09, 2021
    3 years ago
  • Transaction Date
    June 07, 2021
    3 years ago
  • Status Date
    February 09, 2021
    3 years ago
  • Published for Opposition Date
    November 24, 2020
    4 years ago
  • Location Date
    February 09, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    RENNEKER, CHRISTOPHER
  • Attorney Docket Number
    061266.01010
    Attorney Name
    Manuel Valcarcel
    Law Office Assigned Location Code
    N30
  • Owners
Mark Drawing Code
3000
Mark Identification
MIDATECH PHARMA
Case File Statements
  • CC0000: The color(s) blue is/are claimed as a feature of the mark.
  • D10000: "PHARMA"
  • DM0000: The mark consists of the wording "MIDATECH" in dark blue above the wording "PHARMA" in light blue. Next to the wording starts an incomplete circular array of light and blue dots that bend towards the letter "E" in "MIDATECH". White appearing in the mark is background and not claimed as a feature of the mark.
  • GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; nano-particle ingredients for use in pharmaceuticals, medicines and medicated cosmetics for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
  • GS0051: Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles
  • GS0401: Custom manufacture of nano-particles for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
  • GS0421: Scientific research services for others in the field of nano-particle technology; pharmaceutical and drug development and drug discovery services; scientific laboratory services, namely, testing, efficiency evaluation and advisory services in the field of nano-particles and nano-medicine; scientific laboratory services, namely, testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; scientific research laboratory services, namely, nano-particle laboratory services
Case File Event Statements
  • 6/7/2021 - 3 years ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/12/2021 - 3 years ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/12/2021 - 3 years ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/9/2021 - 3 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/9/2021 - 3 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/6/2020 - 4 years ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 11/24/2020 - 4 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/24/2020 - 4 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/18/2020 - 4 years ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/18/2020 - 4 years ago
    21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 11/4/2020 - 4 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/16/2020 - 4 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/23/2020 - 4 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/23/2020 - 4 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/23/2020 - 4 years ago
    16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/23/2020 - 4 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/23/2020 - 4 years ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 9/23/2020 - 4 years ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/23/2020 - 4 years ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/23/2020 - 4 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/23/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/18/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/28/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/27/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/17/2020 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/12/2020 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/11/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/11/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/11/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/5/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR